Literature DB >> 27505677

Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma.

Markus Brockmann, Evon Poon, Teeara Berry, Anne Carstensen, Hedwig E Deubzer, Lukas Rycak, Yann Jamin, Khin Thway, Simon P Robinson, Frederik Roels, Olaf Witt, Matthias Fischer, Louis Chesler, Martin Eilers.   

Abstract

Entities:  

Year:  2016        PMID： 27505677     DOI： 10.1016/j.ccell.2016.07.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  6 in total

Review 1.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

2.  Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma.

Authors:  Joshua Felgenhauer; Laura Tomino; Julia Selich-Anderson; Emily Bopp; Nilay Shah
Journal:  Neoplasia       Date:  2018-08-25       Impact factor: 5.715

Review 3.  Mission Possible: Advances in MYC Therapeutic Targeting in Cancer.

Authors:  Brittany L Allen-Petersen; Rosalie C Sears
Journal:  BioDrugs       Date:  2019-10       Impact factor: 5.807

4.  An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability.

Authors:  Zsuzsanna Nagy; Janith A Seneviratne; Maxwell Kanikevich; William Chang; Chelsea Mayoh; Pooja Venkat; Yanhua Du; Cizhong Jiang; Alice Salib; Jessica Koach; Daniel R Carter; Rituparna Mittra; Tao Liu; Michael W Parker; Belamy B Cheung; Glenn M Marshall
Journal:  Nat Commun       Date:  2021-03-25       Impact factor: 14.919

5.  Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A.

Authors:  Zhuo Bao; Ang Li; Xuebo Lu; Zitong Wang; Yin Yu; Wenjie Wu; Lili Zhao; Bo Li; Xiangyu Wu; Kyle Vaughn Laster; Chengjuan Zhang; Yanan Jiang; Zigang Dong; Kangdong Liu
Journal:  Cell Death Dis       Date:  2022-02-25       Impact factor: 8.469

6.  Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.

Authors:  Margaret Shatara; Kathleen M Schieffer; Darren Klawinski; Diana L Thomas; Christopher R Pierson; Eric A Sribnick; Jeremy Jones; Diana P Rodriguez; Carol Deeg; Elizabeth Hamelberg; Stephanie LaHaye; Katherine E Miller; James Fitch; Benjamin Kelly; Kristen Leraas; Ruthann Pfau; Peter White; Vincent Magrini; Richard K Wilson; Elaine R Mardis; Mohamed S Abdelbaki; Jonathan L Finlay; Daniel R Boué; Catherine E Cottrell; David R Ghasemi; Kristian W Pajtler; Diana S Osorio
Journal:  Acta Neuropathol Commun       Date:  2021-12-11       Impact factor: 7.801
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.